Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q2 2025 · 10-Q
Revenue$681.92M$681.92M+3.3% vs Q2 2024 Net Income-$869.06M-$869.06MN/M vs Q2 2024 EPS Diluted-$11.30-$11.30N/M vs Q2 2024 Operating Income-$39,710,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$20,013,000N/M Margins · derivedOperating margin-5.8%−8.4 pt vs Q2 2024
Net margin-127.4%−122.6 pt vs Q2 2024
ended Jun 30, 2025 · filed Aug 11, 2025 · 42 d after period end